Sparsh Strategic Consulting
DOKIMA
by Sparsh Strategic Consulting  ·  doh-KEE-mah
ICH E6(R3) · GCP
ICH E6(R3) · Principle 2 · Informed Consent

GCP Training That Thinks Like an Inspector.

dokimazō  (δοκιμάζω)
Ancient Greek · To test until genuine quality is proven beyond doubt. The examination Athens required of every public official before office. Not assumed. Proven.

Half of all FDA investigator site inspections find GCP non-compliance. Informed consent appears in the top three findings — every single year.

The sites that failed had complete training records. The problem was never knowledge. It was judgement. DOKIMA trains the judgement that prevents the finding.

"I dokimazed it."
50%+
EMA findings classified critical or major
#3
Informed consent — FDA annual top findings
13
ICH E6(R3) principles — one module each
REF: FDA-WL-2024-IC-007
Inspection Case File
MAJOR
"Subjects enrolled on superseded consent form version following Protocol Amendment 3. IRB-approved version not implemented at time of enrolment."
This finding was preventable. The site knew the rule. The site did not own the reasoning.
DomainInformed Consent
PrincipleICH E6(R3) · P.2
Subjects affected6 of 31
ClassificationMAJOR FINDING
The Full Curriculum
13 Principles. 13 Modules.
One standard across all of them: dokimazed.
02
Informed Consent
▶ Live Now
01
Subject Rights & Wellbeing
Coming Soon
03
IRB / IEC Oversight
Coming Soon
04
Investigator Qualifications
Coming Soon
05
Scientific Soundness
Coming Soon
06
Protocol Compliance
Coming Soon
07
Risk-Based Quality
Coming Soon
08
Investigational Product
Coming Soon
09
Data Quality & Integrity
Coming Soon
10
Confidentiality
Coming Soon
11
IP Manufacturing & Handling
Coming Soon
12
Quality Systems
Coming Soon
13
Systems with Electronic Data
Coming Soon
Licensing
Built for three types of buyer.
One standard: dokimazed.
Tier 1 · Sites
Investigator Sites
SGD 3,500
per site · per year
  • Unlimited staff access
  • Auto-certification, unique ID
  • Training records export
  • Annual content refresh
Tier 3 · Enterprise
Pharma / Sponsors
USD 20,000
enterprise · per year
  • Unlimited sites, one programme
  • Custom inspection findings library
  • Co-branded certification
  • Dedicated QA advisory access
  • Full 13-principle suite
Get in Touch
Start a conversation.

Talk to Sachin directly.

Whether you are exploring a pilot, asking about licensing, or want to understand how DOKIMA fits your inspection readiness programme — reach out directly.

About the Founder

Sachin Pasumamula is the Founder and CEO of Sparsh Strategic Consulting Pte. Ltd. with 25+ years of GxP quality assurance expertise across Asia Pacific. He is also the author of Quiet Watchdogs: The Unsung Heroes of GxP and the inventor of SQIP — the world's first Causal Quality Intelligence Platform (patent filed, Singapore, April 2026).

Send a Message
Your message will be sent to info@sparsh.sg · We respond within 24 hours · Singapore PDPA compliant